QCraft Inc. is a technology company specializing in the development and deployment of autonomous driving solutions for vehicles. Founded in 2019 and headquartered in Mountain View, California, with additional offices in Silicon Valley and various cities in China, QCraft focuses on creating self-driving technology that includes advanced simulation testing systems. These systems train autonomous vehicles to navigate diverse traffic scenarios, including unusual and complex situations, within a virtual environment. The company aims to enhance the safety and efficiency of transportation through its research and development of autonomous vehicles, such as buses and ride-hailing cars, while also promoting environmental sustainability.
Crux Biolabs
Private Equity Round in 2022
Crux Biolabs specializes in providing contract research services focused on immunology for pre-clinical and clinical studies, as well as supporting academic and biotech research and development. The company offers a range of bioanalytical services, including customized biomarker detection and cell assay development. With a particular emphasis on the immuno-oncology sector, Crux Biolabs aids pharmaceutical companies in advancing their clinical development processes, ensuring robust support for their research needs.
Yudao Bio
Series A in 2022
Yudo Bio provides biopharmaceutical products. It has its headquarters in Shanghai in China.
Bluepha is a company that specializes in synthetic biotechnology, integrating bioengineering and data science to create innovative bio-based products. It focuses on the research and development of microbial manufacturing and material innovation, applying synthetic biology to optimize cells for diverse applications, including energy and pharmaceuticals. Bluepha aims to deliver value across various industries such as consumer goods, healthcare, specialty chemicals, agriculture, and electronics. By leveraging bio-engineering techniques, the company enables clients to assemble products from engineered cell materials, advancing the field of bio-manufacturing.
CATUG Biotechnology
Venture Round in 2022
CATUG Biotechnology specializes in the development and application of innovative biomedical technologies, particularly in the realm of gene therapy and nucleic acid drugs. The company offers comprehensive contract development and manufacturing organization (CDMO) services that span the entire industry chain, from research and development to clinical applications and industrialization. With research and development centers and industrialization bases situated in Suzhou and Wuhan, CATUG is well-equipped to support the drug research and production needs of its clients.
Xiaohongshu
Series E in 2021
Xiaohongshu, founded in 2013 and based in Shanghai, China, is a lifestyle sharing platform that allows users to share experiences through text, images, and videos. Initially aimed at assisting overseas travelers with shopping, it has transformed into a vibrant community focused on various lifestyle areas, including cosmetics, fashion, food, travel, entertainment, reading, fitness, and childcare. The platform serves as a social e-commerce space where users can post their favorite products, share shopping experiences, and discover global merchandise, particularly in luxury and beauty sectors. By fostering user-generated content, Xiaohongshu encourages a collaborative environment for lifestyle enthusiasts to exchange insights and recommendations.
Tinyman
Seed Round in 2021
Tinyman is a decentralized trading protocol built on the Algorand blockchain, providing a secure and efficient marketplace for traders, liquidity providers, and developers. The company focuses on creating an open platform that facilitates asset trading and swapping, including tokens and currencies, at market rates. By leveraging blockchain technology, Tinyman acts as a market maker, ensuring that users can engage in secure trading activities while benefiting from the speed and reliability of its underlying framework. This innovative approach positions Tinyman as a significant player in the decentralized finance space.
QCraft Inc. is a technology company specializing in the development and deployment of autonomous driving solutions for vehicles. Founded in 2019 and headquartered in Mountain View, California, with additional offices in Silicon Valley and various cities in China, QCraft focuses on creating self-driving technology that includes advanced simulation testing systems. These systems train autonomous vehicles to navigate diverse traffic scenarios, including unusual and complex situations, within a virtual environment. The company aims to enhance the safety and efficiency of transportation through its research and development of autonomous vehicles, such as buses and ride-hailing cars, while also promoting environmental sustainability.
neoX Biotech
Venture Round in 2021
neoX Biotech is a Beijing-based biotechnology company founded in 2018 that specializes in the development of antigen-based cancer vaccines. By integrating artificial intelligence with biophysics, neoX Biotech focuses on the discovery and development of macromolecular and multispecific drugs, primarily in the field of immuno-oncology. The company has established a platform for early therapeutic discovery, which includes neoantigen prediction and T cell receptor screening, as well as the characterization of protein-protein interactions. This innovative approach aims to provide effective treatments for cancer patients by advancing drug research and development.
Ainnocence
Seed Round in 2021
Ainnocence is a biotechnology company focused on revolutionizing drug discovery and development. The company aims to create an intelligent, self-evolving platform that combines advanced computational methods with wet lab technologies. This platform is designed to address critical, unmet medical needs by rapidly screening and optimizing various therapeutic modalities, including small-molecule drugs and antibodies. Ainnocence's third-generation artificial intelligence system significantly accelerates the discovery process, reducing both time and cost. The company's approach enables it to tackle complex biological targets that traditional methods struggle with, thereby enhancing the efficiency and effectiveness of drug development.
Zhongxuegao
Series A in 2021
Zhongxuegao is a Chinese ice cream brand. Zhong Xuegao is taking the route of high-end Chinese-style ice cream. Zhong Xuegao has made many innovative attempts in the expression of flavors in different regions, including light/special milk, velvet cocoa, and Ireland Ice cream products with different flavors such as aged cheese, hand-cooked jasmine, and wine-stuffed roses. Zhong Xuegao also launched a series of themed joint products with Luzhou Laojiao , Naixue's Tea, Wufangzhai, Hema, Wahaha AD calcium milk and other brands. Zhong Xuegao’s offline business has been in operation for a long time, and the brand began to deploy offline channels in the first year of its establishment, and has now opened more than 20 offline stores.
Genki Forest
Series C in 2020
Genki Forest is a beverage company that focuses on producing sugar-free and low-calorie drinks, catering to consumers seeking healthy and flavorful options. The company specializes in manufacturing a range of beverages, including sugar-free tea and flavored seltzer water, created from natural ingredients. Genki Forest aims to provide affordable, health-conscious beverages, aligning with the growing demand for nutritious drink alternatives in the market.
Volcan Craft
Series B in 2020
Volcan Craft, also known as Shanghai Kaishan Wine Co., Ltd., is a liquor brand established in 2017 and headquartered in Shanghai, China. The company focuses on producing and selling a variety of alcoholic beverages, catering primarily to the tastes of young consumers. Volcan Craft employs a hybrid business model that combines both online and offline sales channels to enhance accessibility and engagement with its target market. Through its innovative approach, the brand aims to establish a strong presence in the competitive liquor industry.
Chayan Yuese
Series A in 2019
ChaYanYueSe is a prominent milk tea franchise based in Changsha, China, established in mid-2014. It is recognized as the first milk tea brand in the country to embrace a traditional Chinese style, offering a unique cultural approach to its beverage offerings. The franchise specializes in a variety of crafted beverages, including cream-topped tea lattes and milk tea, aimed at delivering an innovative and enjoyable tea-drinking experience. ChaYanYueSe operates from its headquarters located on Huangxing Pedestrian Street and provides comprehensive information on franchise opportunities, including fees and discounts, through its official website.
Yaoyanshe
Series C in 2019
Yaoyanshe, established in 2012 and headquartered in Shanghai, China, operates as a Contract Research Organization (CRO) technology platform. It specializes in providing end-to-end services for pharmaceutical research and development, including clinical monitoring, project management, registration affairs, biostatistics, pharmacovigilance, medical affairs, and Site Management Organization (SMO) services. The company's core offering is an application designed to facilitate value sharing and trading within the industry, empowering patients with up-to-date treatment information and enabling professionals to assess creditworthiness, analyze competition, and evaluate sponsor projects more effectively. Yaoyanshe aims to address key industry challenges and enhance the efficiency of pharmaceutical research and development.
Kzmall.cn
Series B in 2019
Kzmall.cn is a Chinese company based in Hangzhou, founded in 2015, operating an online B2B platform tailored for auto repair companies. It offers a comprehensive supply chain service, connecting with major domestic and international auto parts manufacturers to deliver genuine parts directly from factories to repair shops. This approach enhances efficiency, transparency, and reliability in the supply chain. The company has established strategic partnerships with leading global auto parts brands and aims to cover all counties and cities in China with over 2,500 service stations by 2020. Kzmall.cn provides a range of services including finance, insurance, logistics, training, tech support, and IT solutions, catering to more than 100,000 repair shops nationwide.
BeeXplore Technology
Seed Round in 2019
BeeXplore Technology is an agency specializing in the investment and incubation of the blockchain industry. It is headquartered in Seychelles and has a total of 10 billion issued by the B360 Token. At the same time, BeeXplore Technology has reached a deep strategic cooperation with the distributed personalized search engine Bee360, and its eco-pass can be used in the Bee360 product ecosystem.
Sunvou
Corporate Round in 2019
Sunvou is a company focused on developing advanced molecular exhalation diagnostics for in vitro diagnostic products aimed at diagnosing respiratory diseases. Founded in 2008 by Dr. Han Jie, who has extensive experience in biomedical sensor technology, the company leverages its expertise to identify biomarker molecules in the respiratory system at a nanoscale level. This innovative approach enables healthcare practitioners to diagnose and target a range of respiratory, gastrointestinal, and cardiovascular diseases effectively. Sunvou operates market and product centers in Shanghai and Wuxi, China, and is supported by a team of research and development and manufacturing executives based in Europe and America. Dr. Han Jie’s contributions to the field have been recognized through numerous awards, and he has authored a significant number of publications and participated in key projects related to nanobiomedicine.
Zhenkunxing
Series D in 2019
ZKH is a digital service platform for industrial products that offers comprehensive supply chain solutions based on an E-commerce platform, digital tools, and intelligent service. Its platform offers a comprehensive selection of industrial accessories, consumables, general equipment, and spare parts. There are 28 product lines and over 4 million SKUs available, including PPE, hand tools, metal processing, fasteners, instruments, chemicals, and so on.
NewBanker
Series B in 2019
NewBanker, formally known as Beijing Niubitou Science and Technology Consulting, specializes in providing comprehensive support services for the wealth management industry in China. The company is founded by experienced managers from prominent wealth management firms and focuses on delivering information, research, technology, capital, and resources to wealth management companies and financial advisors. NewBanker develops customer relationship management software tailored for the wealth management sector, offering a SaaS/PaaS business support system that includes various services such as strategic research, industry information, investor education, and high-end training. Additionally, the firm provides a site acquisition system and technical support, ensuring its clients have access to essential tools and insights necessary for effective customer acquisition and industry promotion.
Yaoyanshe
Series B in 2018
Yaoyanshe, established in 2012 and headquartered in Shanghai, China, operates as a Contract Research Organization (CRO) technology platform. It specializes in providing end-to-end services for pharmaceutical research and development, including clinical monitoring, project management, registration affairs, biostatistics, pharmacovigilance, medical affairs, and Site Management Organization (SMO) services. The company's core offering is an application designed to facilitate value sharing and trading within the industry, empowering patients with up-to-date treatment information and enabling professionals to assess creditworthiness, analyze competition, and evaluate sponsor projects more effectively. Yaoyanshe aims to address key industry challenges and enhance the efficiency of pharmaceutical research and development.
Beijing Beisen Cloud Computing Co., Ltd. specializes in developing software as a service (SaaS) solutions for integrated talent management. Founded in 2005 and based in Beijing, the company offers a comprehensive platform that includes services for talent assessment, recruitment management, performance management, succession planning, and employee development. Beisen’s Human Resource Service Platform focuses on internet recruitment, while its Business People Service Network provides information and recruitment services. The company also delivers platform as a service (PaaS) for cloud architecture development, along with system implementation and custom development services. Its iTalentX platform features cloud-native applications designed to streamline human capital management (HCM) processes, enabling organizations to effectively recruit, evaluate, and retain talent throughout the employee lifecycle.
Zhenkunxing
Series C in 2018
ZKH is a digital service platform for industrial products that offers comprehensive supply chain solutions based on an E-commerce platform, digital tools, and intelligent service. Its platform offers a comprehensive selection of industrial accessories, consumables, general equipment, and spare parts. There are 28 product lines and over 4 million SKUs available, including PPE, hand tools, metal processing, fasteners, instruments, chemicals, and so on.
Zhenkunxing
Series B in 2017
ZKH is a digital service platform for industrial products that offers comprehensive supply chain solutions based on an E-commerce platform, digital tools, and intelligent service. Its platform offers a comprehensive selection of industrial accessories, consumables, general equipment, and spare parts. There are 28 product lines and over 4 million SKUs available, including PPE, hand tools, metal processing, fasteners, instruments, chemicals, and so on.
HealthCare Biotech
Series A in 2017
Kanglu Bio is positioned to provide clinical diagnosis and guidance for clinical drug molecular diagnostic products and clinical molecular diagnostics overall service providers for clinical hospitals and third-party clinical independent testing institutions. The products and services are mainly used in cardiovascular and cerebrovascular diseases. Major diseases such as tumors and cancer.
TaiMei Technology
Series C in 2017
TaiMei Technology is a digital innovator in the life sciences sector, specializing in research and development solutions. The company has created a comprehensive integrated digital platform that supports clinical research and offers deep insights into various aspects of drug development, including pharmacovigilance, marketing, and market access. By leveraging advanced technologies such as artificial intelligence, big data, cloud computing, and mobile internet, TaiMei Technology provides innovative solutions that enhance the efficiency of clinical research and improve the overall product lifecycle. Its platform is designed to facilitate the acceleration of product launches, elevate drug safety, increase drug accessibility, and alleviate the medical burden on both patients and healthcare providers.
Haozu.com
Series B in 2016
Haozu.com is a prominent Chinese platform dedicated to providing house renting information and services. Launched in 2009, it is part of a larger group that includes Anjuke.com, which focuses on house-buying information, and other commercial real estate services. Haozu.com has established a significant presence in 58 major cities, including Shanghai, Beijing, and Guangzhou, offering nearly 700,000 rental housing resources. The platform attracts an average of 500,000 users daily seeking rental information. Additionally, Haozu's mobile application has gained popularity among renters, amassing over 4.5 million users, which accounts for 74% of the rental app market in China. The company utilizes cloud computing and big data to enhance its services, providing a comprehensive solution for tenants and property owners alike.
DataVisor
Series B in 2016
DataVisor Inc. is a technology company specializing in fraud and financial crime detection through advanced big data solutions. Founded in 2013 and headquartered in Mountain View, California, the company employs unsupervised machine learning to identify and predict attack vectors across various user accounts. Its flagship products include dCube, a proactive fraud management solution that detects known and unknown fraud, and dVector, which provides accurate fraud signals and contextual analysis for effective decision-making. DataVisor also offers dEdge, which gathers real-time intelligence from connected devices to safeguard mobile and web applications against manipulation and threats. The company's solutions address a wide range of issues, including account takeovers, fake accounts, transaction fraud, and content moderation, serving industries such as financial services, e-commerce, social platforms, and telecommunications.
Tiebaobei
Series C in 2016
Tiebaobei is a Beijing-based company that specializes in the development and operation of a trading platform for used construction equipment. As a leader in the second-hand construction machinery service sector, the company is dedicated to creating a consumer-to-consumer (C2C) trading model that leverages the Internet to address the challenges commonly associated with traditional second-hand machinery transactions. Tiebaobei aims to provide a fair, efficient, and user-friendly platform for buyers around the world, thereby transforming the landscape of used construction equipment trading.
Iron Armour
Series C in 2016
Iron Armour is China TOP 1 online service platform in construction equipment industry. We focus on equipment trading services & equipment management, and we offer diversity choice and service to our customer, which including consignment service, online auction , web portal, and equipment management based on IoT.
AusperBio is a clinical-stage biopharmaceutical company focused on developing innovative treatments for hepatitis B and advancing oligonucleotide therapeutics. Utilizing its proprietary Med-Oligo™ ASO platform, AusperBio aims to deliver effective targeted therapies that leverage antisense oligonucleotide technology. The company is dedicated to transforming the treatment landscape for hepatitis B, with an emphasis on finding a cure and providing protection through novel therapeutic approaches. Additionally, AusperBio's research extends to addressing a variety of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases, thereby broadening the potential impact of its therapeutic innovations.